Skip to main content
logo
Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
10.41
+0.80 (8.32%)
At close: Aug 7, 2026, 4:00 PM EDT
10.42
+0.01 (0.10%)
After-hours: Aug 7, 2026, 6:29 PM EDT

Turn Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
11.225.080.871.18
Cash & Short-Term Investments
11.225.080.871.18
Cash Growth
1185.55%481.73%-26.11%-
Other Current Assets
0.240.120.230.02
Total Current Assets
11.455.21.11.2
Net Property, Plant & Equipment
0.070.080.120.03
Other Intangible Assets
0.920.920.820.77
Other Long-Term Assets
6.25.960.010.01
Total Assets
18.6412.162.052.01

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Accounts Payable
2.322.930.670.46
Current Portion of Leases
0.050.050.040.03
Other Current Liabilities
2.773.03--
Total Current Liabilities
5.1360.710.49
Long-Term Debt
5.94---
Long-Term Leases
0.020.030.08-
Other Long-Term Liabilities
1.441.441.441.44
Total Long-Term Liabilities
7.41.471.521.44
Total Liabilities
12.537.482.231.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Common Stock
---0
Additional Paid-in Capital
29.4828.1419.0217.51
Accumulated Other Comprehensive Income
--1.07--
Retained Earnings
-23.36-22.39-19.2-17.43
Shareholders' Equity
6.124.69-0.180.09
Total Liabilities & Equity
18.6412.162.052.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Total Debt
6.010.080.120.03
Net Cash (Debt)
5.2150.751.16
Net Cash Growth
593.47%564.72%-34.98%-
Net Cash Per Share
0.180.180.030.04
Book Value
6.124.69-0.180.09
Book Value Per Share
0.220.17-0.010.00
Tangible Book Value
5.23.76-1-0.68
Tangible Book Value Per Share
0.180.14-0.04-0.03
SEC Filings: 10-K · 10-Q